Filing Details

Accession Number:
0001225208-10-017569
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-07-27 13:00:00
Reporting Period:
2010-07-23
Filing Date:
2010-07-27
Accepted Time:
2010-07-27 11:54:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
732485 Genzyme Corp GENZ Biological Products, (No Disgnostic Substances) (2836) 061047163
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1243004 D Sandford Smith 500 Kendall Street
Cambridge MA 02142
Exe Vp,President Int'l Group No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Genzyme Common Stock (Genz) Acquisiton 2010-07-23 22,800 $43.90 43,471 No 4 M Direct
Genzyme Common Stock (Genz) Acquisiton 2010-07-23 9,000 $46.24 52,471 No 4 M Direct
Genzyme Common Stock (Genz) Acquisiton 2010-07-23 241 $41.50 52,712 No 4 M Direct
Genzyme Common Stock (Genz) Disposition 2010-07-23 2,300 $63.75 50,412 No 4 S Direct
Genzyme Common Stock (Genz) Disposition 2010-07-23 9,000 $66.10 41,412 No 4 S Direct
Genzyme Common Stock (Genz) Disposition 2010-07-23 20,741 $63.75 20,671 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Genzyme Common Stock (Genz) Stock Option (right to buy) Disposition 2010-07-23 241 $41.50 241 $41.50
Genzyme Common Stock (Genz) Stock Option (right to buy) Disposition 2010-07-23 9,000 $46.24 9,000 $46.24
Genzyme Common Stock (Genz) Stock Option (right to buy) Disposition 2010-07-23 22,800 $43.90 22,800 $43.90
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2002-05-30 2012-05-30 No 4 M Direct
0 2003-05-29 2013-05-29 No 4 M Direct
0 2004-05-27 2014-05-27 No 4 M Direct
Footnotes
  1. The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 19, 2009.